With the use of intravital fluorescence microscopy and the dorsal skinfold chamber model we studied the effect of buflomedil hydrochloride on micro-vascular reperfusion injury after 4 h of tourniquet-induced ischemia in hamster striated muscle. Animals (n = 15) received 3 mg/kg buflomedil (i.v. bolus) 5 min before onset of reperfusion, and 3 mg/kg buflomedil (continuous i.v. infusion) during the first 20 min of reperfusion. Animals (n = 13) receiving equivalent volumes of saline served as controls. Tourniquet-induced ischemia resulted in (a) a marked decrease of functional capillary density and (b) accumulation and adherence of leukocytes in postcapillary venules after 30 min and 2 h of reperfusion. This was associated with an increased microvascular permeability (leakage of macromolecules), reflecting the alteration of endothelial cell integrity. Treatment with buflomedil significantly reduced both postischemic capillary perfusion failure and leukocyte adherence in venules. Concomitantly, the increase of microvascular permeability in postcapillary venules was almost prevented, indicating the beneficial effect of buflomedil on the manifestation of microvascular reperfusion injury following tourniquet ischemia in striated muscle.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.